| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/16/2004 | US20040254216 Inhibitors of p38 |
| 12/16/2004 | US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/16/2004 | US20040254211 Alpha v integrin receptor antagonists |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254203 Methods and compositions utilizing quinazolinones |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 12/16/2004 | US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
| 12/16/2004 | US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 12/16/2004 | US20040254182 Enhanced propertied pharmaceuticals |
| 12/16/2004 | US20040254178 Substituted heterocyclic compounds and methods of use |
| 12/16/2004 | US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 12/16/2004 | US20040254157 ethyl 4-[(4-[[2-methyl-phenyl)amino]carbonyl]amino)phenyl]amino]-4-oxo-2-phenyl-butanoyl)amino]benzoate for treatment of inflammatory diseases and conditions mediated by integrins (atherosclerosis, asthma, obstructive pulmonary disease, allergies, diabetes, multiple sclerosis, and autoimmune disorders) |
| 12/16/2004 | US20040254151 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents |
| 12/16/2004 | US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents |
| 12/16/2004 | US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253321 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 12/16/2004 | US20040253301 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects |
| 12/16/2004 | US20040253181 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 12/16/2004 | CA2528925A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | CA2528164A1 Solid preparation |
| 12/16/2004 | CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 12/16/2004 | CA2526694A1 Amidino compounds as cysteine protease inhibitors |
| 12/15/2004 | EP1486497A1 Novel pyridone derivative |
| 12/15/2004 | EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels |
| 12/15/2004 | EP1486494A1 N-substituted benzothiophenesulfonamide derivative |
| 12/15/2004 | EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1486213A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 12/15/2004 | EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis |
| 12/15/2004 | EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 12/15/2004 | EP1486206A1 New uses for amino acid anticonvulsants for treatment of bipolare disorder |
| 12/15/2004 | EP1486205A1 New uses for amino acid anticonvulsants for treatment of migraine |
| 12/15/2004 | EP1485476A2 Dimeric tf antagonist |
| 12/15/2004 | EP1485393A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 12/15/2004 | EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| 12/15/2004 | EP1485375A1 Pyrimidine compounds |
| 12/15/2004 | EP1485374A1 Pyrimidine compounds |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485362A1 Crystalline parecoxib sodium |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485347A2 Hif hydroxylase inhibitors |
| 12/15/2004 | EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators |
| 12/15/2004 | EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 12/15/2004 | EP1485127A2 Administration of agents for the treatment of inflammation |
| 12/15/2004 | EP1485114A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 12/15/2004 | EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485098A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine in nanoparticulate form |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/15/2004 | EP1485081A1 Ibuprofen solution for hard shell capsules |
| 12/15/2004 | EP1485074A2 Compositions for treating digestive functional pathologies |
| 12/15/2004 | EP1436285A4 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 12/15/2004 | EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 12/15/2004 | EP1399155A4 Small molecules useful in the treatment of inflammatory disease |
| 12/15/2004 | EP1322301B1 Combination particles for the treatment of asthma |
| 12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
| 12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/15/2004 | EP1301517B1 Thienopyrrolidinones |
| 12/15/2004 | EP1263711B1 Novel use of phenylheteroalkylamine derivatives |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1218005B1 Vitronectin receptor antagonists |
| 12/15/2004 | EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 12/15/2004 | EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/15/2004 | EP0921785B1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 12/15/2004 | EP0630252B1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases |
| 12/15/2004 | CN1555488A Lymphatic endothelial cells materials and methods |
| 12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
| 12/15/2004 | CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 12/15/2004 | CN1555375A Compounds for inhibiting the release of inflammatory cytokines |
| 12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
| 12/15/2004 | CN1555272A Compositions and methods for modulation of immune responses |
| 12/15/2004 | CN1555270A Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme, and the use of said extracts |
| 12/15/2004 | CN1555266A Hormone replacement therapy |
| 12/15/2004 | CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier |